Journey Medical (DERM) Other Working Capital Changes (2020 - 2026)
Journey Medical's (DERM) quarterly Other Working Capital Changes came in at -$25000.0 in Q1 2026, down 78.57% YoY from -$116666.7 in Q1 2025, and down 8.7% on a QoQ basis from -$23000.0 in Q4 2025.
Journey Medical (DERM) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Other Working Capital Changes data on file, last reported at -$25000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 78.57% year-over-year to -$25000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$93000.0 (down 8.14% YoY) and the FY2025 annual result came in at -$82000.0, up 14.58% from the prior year.
- Other Working Capital Changes declined to -$25000.0 in Q1 2026, from -$23000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.7 million in Q4 2023 to a low of -$1.2 million in Q3 2024.
- A 5-year average of $27647.1 and a median of -$32000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 41.67% — and 2026, when it sank 78.57%.
- Tracing DERM's Other Working Capital Changes over 5 years: stood at -$22000.0 in 2022, then decreased by 4.55% to -$23000.0 in 2023, then climbed by 4.35% to -$22000.0 in 2024, then decreased by 4.55% to -$23000.0 in 2025, then fell by 8.7% to -$25000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$25000.0 (Q1 2026), -$23000.0 (Q4 2025), and -$23000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -728,000.00 |
| Jun 30, 2026 | -728,000.00 |
| Jun 30, 2026 | -728,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | -841,000.00 |
| Sep 30, 2025 | -841,000.00 |
| Sep 30, 2025 | -841,000.00 |
| Jun 30, 2025 | 84,000.00 |
| Jun 30, 2025 | 84,000.00 |
| Jun 30, 2025 | 84,000.00 |
| Mar 31, 2025 | -817,000.00 |
| Mar 31, 2025 | -817,000.00 |
| Mar 31, 2025 | -817,000.00 |
| Dec 31, 2024 | 2.34 Mn |
| Dec 31, 2024 | 2.34 Mn |